The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
Open accessAbstract
Aberrant T-cell activation underlies many autoimmune disorders, yet most attempts to induce T-cell tolerance have failed. Building on previous strategies for tolerance induction that exploited natural mechanisms for clearing apoptotic debris, we show that antigen-decorated microparticles (500-nm diameter) induce long-term T-cell tolerance in mice with relapsing experimental autoimmune encephalomyelitis. Specifically, intravenous infusion of either polystyrene or biodegradable poly(lactide-co-glycolide) microparticles bearing encephalitogenic peptides prevents the onset and modifies the course of the disease. These beneficial effects require microparticle uptake by marginal zone macrophages expressing the scavenger receptor MARCO and are mediated in part by the activity of regulatory T cells, abortive T-cell activation and T-cell anergy. Together these data highlight the potential for using microparticles to target natural apoptotic clearance pathways to inactivate pathogenic T cells and halt the disease process in autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
Chen, Y., Kuchroo, V. K., Inobe, J.-I., Hafler, D. A., & Weiner, H. L. (1994) · Science · doi:10.1126/science.7520605 · Cited by 1,973
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Bailey, S. L., Schreiner, B., McMahon, E. J., & Miller, S. D. (2007) · Nature Immunology · doi:10.1038/ni1430 · Cited by 463
Self-citationThe Time Has Come: Bayesian Methods for Data Analysis in the Organizational Sciences
Kruschke, J. K., Aguinis, H., & Joo, H. (2012) · Organizational Research Methods · doi:10.1177/1094428112457829 · Cited by 457
CD3-specific antibodies: a portal to the treatment of autoimmunity
Chatenoud, L., & Bluestone, J. A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2134 · Cited by 388
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
Ludvigsson, J., Krisky, D., Casas, R., Battelino, T., Castaño, L., Greening, J., Kordonouri, O., Otonkoski, T., Pozzilli, P., Robert, J.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107096 · Cited by 340
Reversal of in vitro T cell clonal anergy by IL-2 stimulation
Beverly, B., Kang, S.-M., Lenardo, M. J., & Schwartz, R. H. (1992) · International Immunology · doi:10.1093/intimm/4.6.661 · Cited by 333
Kohm, A. P., McMahon, J. S., Podojil, J. R., Begolka, W. S., DeGutes, M., Kasprowicz, D. J., Ziegler, S. F., & Miller, S. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3301 · Cited by 332
Self-citationScavenger receptors: role in innate immunity and microbial pathogenesis
Areschoug, T., & Gordon, S. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01326.x · Cited by 317
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease
Miller, S. D., Turley, D. M., & Podojil, J. R. (2007) · Nature Reviews Immunology · doi:10.1038/nri2153 · Cited by 290
Self-citationClonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
DeSilva, D. R., Urdahl, K. B., & Jenkins, M. K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3261 · Cited by 250
Palecanda, A., Paulauskis, J., Al-Mutairi, E., Imrich, A., Qin, G., Suzuki, H., Kodama, T., Tryggvason, K., Koziel, H., & Kobzik, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1497 · Cited by 244
Herold, K. C., Gitelman, S., Greenbaum, C., Puck, J., Hagopian, W., Gottlieb, P., Sayre, P., Bianchine, P., Wong, E., Seyfert-Margolis, V., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.04.007 · Cited by 219
Vanderlugt, C. L., Neville, K. L., Nikcevich, K. M., Eagar, T. N., Bluestone, J. A., & Miller, S. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.670 · Cited by 213
Self-citationGetts, D. R., Turley, D. M., Smith, C. E., Harp, C. T., McCarthy, D., Feeney, E. M., Getts, M. T., Martin, A. J., Luo, X., Terry, R. L., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004175 · Cited by 198
Self-citationFollicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8
Kranich, J., Krautler, N. J., Heinen, E., Polymenidou, M., Bridel, C., Schildknecht, A., Huber, C., Kosco-Vilbois, M. H., Zinkernagel, R., Miele, G., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071019 · Cited by 181
Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
Garren, H., Robinson, W. H., Krasulová, E., Havrdová, E., Nadj, C., Selmaj, K., Losy, J., Nadj, I., Radue, E., Kidd, B. A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21370 · Cited by 181
Lalive, P. H., Neuhaus, O., Benkhoucha, M., Burger, D., Hohlfeld, R., Zamvil, S. S., & Weber, M. S. (2011) · CNS Drugs · doi:10.2165/11588120-000000000-00000 · Cited by 176
Kang, Y.-S. (2003) · International Immunology · doi:10.1093/intimm/dxg019 · Cited by 170
Luo, X., Pothoven, K. L., McCarthy, D., DeGutes, M., Martin, A., Getts, D. R., Xia, G., He, J., Zhang, X., Kaufman, D. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805204105 · Cited by 165
Self-citationImmunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
Luo, X., Herold, K. C., & Miller, S. D. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.002 · Cited by 139
Self-citationA phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Freedman, M. S., Bar‐Or, A., Oger, J. J.-F., Traboulsee, A. L., Patry, D., Young, C. A., Olsson, T. P., Li, D., Hartung, H. ‐., Krantz, M. J., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318233b240 · Cited by 137
Dahl, M., Bauer, A. K., Arredouani, M. S., Soininen, R., Tryggvason, K., Kleeberger, S. R., & Kobzik, L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29968 · Cited by 136
A Murine Scavenger Receptor MARCO Recognizes Polystyrene Nanoparticles
Kanno, S., Furuyama, A., & Hirano, S. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm050 · Cited by 131
Turley, D. M., & Miller, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2212 · Cited by 126
Self-citationPD‐1 ligands expressed on myeloid‐derived APC in the CNS regulate T‐cell responses in EAE
Schreiner, B., Bailey, S. L., Shin, T., Chen, L., & Miller, S. D. (2008) · European Journal of Immunology · doi:10.1002/eji.200838137 · Cited by 104
Self-citationSmith, C., Eagar, T. N., Strominger, J. L., & Miller, S. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504131102 · Cited by 94
Self-citationAutoimmunity versus tolerance: Can dying cells tip the balance?
Viorritto, I. C. B., Nikolov, N. P., & Siegel, R. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.07.012 · Cited by 89
Thelen, T. D., Hao, Y., de Medeiros, A. I., Curtis, J. L., Serezani, C. H., Kobzik, L., Harris, L. H., & Aronoff, D. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000989 · Cited by 89
Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of Allergy
Smarr, C. B., Hsu, C., Byrne, A. J., Miller, S. D., & Bryce, P. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100608 · Cited by 81
Self-citationChristen, U., & von Herrath, M. G. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.002 · Cited by 80
Differential Binding of Inorganic Particles to MARCO
Thakur, S. A., Hamilton, R. F., Pikkarainen, T., & Holian, A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn210 · Cited by 69
Arredouani, M. S., Franco, F., Imrich, A., Fedulov, A. V., Lu, X., Perkins, D. L., Soininen, R., Tryggvason, K., Shapiro, S. D., & Kobzik, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5912 · Cited by 67
Ilan, Y., Zigmond, E., Lalazar, G., Dembinsky, A. V., Yaʼacov, A. B., Hemed, N., Kasis, I., Axelrod, E., Zolotarov, L., Klein, A., et al. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9323-7 · Cited by 67
MARCO Regulates Early Inflammatory Responses against Influenza
Ghosh, S. T., Gregory, D. J., Smith, A. G., & Kobzik, L. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0349oc · Cited by 66
Considerations When Submitting Nanotherapeutics to FDA/CDER for Regulatory Review
Tyner, K. M., & Sadrieh, N. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_3 · Cited by 57
Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective
Racke, M. K., & Lovett‐Racke, A. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1090138 · Cited by 48
Prevention of type 1 diabetes: the time has come
Sherr, J. L., Sosenko, J. M., Skyler, J. S., & Herold, K. C. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0832 · Cited by 48
Eagar, T. N., Turley, D. M., Padilla, J., Karandikar, N. J., Tan, L., Bluestone, J. A., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7442 · Cited by 32
Self-citationHigh‐Dose Soluble Antigen: Peripheral T‐Cell Proliferation or Apoptosis
Liblau, R., Pearson, C. I., Shokat, K. M., Tisch, R., Yang, X., & McDevitt, H. O. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00890.x · Cited by 29
Martin, A. J., McCarthy, D. P., Waltenbaugh, C. R., Goings, G. E., Luo, X., & Miller, S. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000802 · Cited by 23
Self-citationMultiple Sclerosis Therapies: Molecular Mechanisms and Future
da Fontoura, P. P., & Garren, H. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2010_36 · Cited by 23
Evolution of MS lesions to black holes under DNA vaccine treatment
Papadopoulou, A., von Felten, S., Traud, S., Rahman, A., Quan, J. M., King, R., Garren, H., Steinman, L., Cutter, G., Kappos, L., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6361-x · Cited by 19
Kohm, A. P., Turley, D. M., & Miller, S. D. (2005) · International Reviews of Immunology · doi:10.1080/08830180500371207 · Cited by 16
Self-citationSIGN-R1+MHC II+ cells of the splenic marginal zone—a novel type of resident dendritic cells
Łyszkiewicz, M., Ziętara, N., Rohde, M., Gekara, N. O., Jabłońska, J., Dittmar, K. E. J., & Weiß, S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610368 · Cited by 7
Cited by
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 594
Nanotechnology and its Applications in Medicine
Nikalje, A. P. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000247 · Cited by 512
Expanding antigen-specific regulatory networks to treat autoimmunity
Clemente-Casares, X., Blanco, J., Ambalavanan, P., Yamanouchi, J., Singha, S., Fandos, C., Tsai, S., Wang, J., Garabatos, N., Izquierdo, C., et al. (2016) · Nature · doi:10.1038/nature16962 · Cited by 510
Cell membrane-derived nanomaterials for biomedical applications
Fang, R. H., Jiang, Y., Fang, J. C., & Zhang, L. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.041 · Cited by 468
Metadata
- Authors
- Getts, D. R., Martin, A. J., McCarthy, D. P., Terry, R. L., Hunter, Z. N., Yap, W. T., Getts, M. T., Pleiss, M., Luo, X., King, N. J., Shea, L. D., & Miller, S. D.
- Venue
- Nature Biotechnology
- Published
- 2012-11-18
- Volume
- 30
- Issue
- 12
- Pages
- 1217-1224
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1978684572
- Cited by
- 392
- References
- 48
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.